These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36014980)

  • 21. Detection of NDM-1 and VIM Genes in Carbapenem-Resistant Klebsiella pneumoniae Isolates from a Tertiary Health-Care Center in Kathmandu, Nepal.
    Thapa S; Adhikari N; Shah AK; Lamichhane I; Dhungel B; Shrestha UT; Adhikari B; Banjara MR; Ghimire P; Rijal KR
    Chemotherapy; 2021; 66(5-6):199-209. PubMed ID: 34515078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of specific inhibitors on metallo-β-carbapenemases detected in Escherichia coli and Klebsiella pneumoniae isolates.
    Abbas HA; Kadry AA; Shaker GH; Goda RM
    Microb Pathog; 2019 Jul; 132():266-274. PubMed ID: 31096002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissemination of ST101 blaOXA-48 producing Klebsiella pneumoniae at tertiary care setting.
    ElMahallawy H; Zafer MM; Al-Agamy M; Amin MA; Mersal MM; Booq RY; Alyamani E; Radwan S
    J Infect Dev Ctries; 2018 Jun; 12(6):422-428. PubMed ID: 31940293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial Resistance Patterns of Gram-negative Bacteria in an Iranian Referral Pediatric Hospital: A Present Danger of New Delhi Metallo-β- lactamase.
    Mahmoudi S; Pourakbari B; Rostamyan M; Raji H; Sadeghi RH; Mamishi S
    Infect Disord Drug Targets; 2023; 23(6):e180423215994. PubMed ID: 37106518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of carbapenem-resistant
    Yan WJ; Jing N; Wang SM; Xu JH; Yuan YH; Zhang Q; Li AL; Chen LH; Zhang JF; Ma B; Ma Q; Li Y
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33587030
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibiotic resistance and detection of plasmid mediated colistin resistance mcr-1 gene among Escherichia coli and Klebsiella pneumoniae isolated from clinical samples.
    Karki D; Dhungel B; Bhandari S; Kunwar A; Joshi PR; Shrestha B; Rijal KR; Ghimire P; Banjara MR
    Gut Pathog; 2021 Jul; 13(1):45. PubMed ID: 34225805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a new spectrophotometric assay for rapid detection and differentiation of KPC, MBL and OXA-48 carbapenemase-producing Klebsiella pneumoniae clinical isolates.
    Routsias JG; Tsakogiannis D; Katsiki M; Marinou D; Mavrouli M; Vrioni G; Tsakris A
    Int J Antimicrob Agents; 2020 Dec; 56(6):106211. PubMed ID: 33172591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamic evaluation of meropenem, cefepime, or aztreonam combined with a novel β-lactamase inhibitor, nacubactam, against carbapenem-resistant and/or carbapenemase-producing Klebsiella pneumoniae and Escherichia coli using a murine thigh-infection model.
    Hagihara M; Kato H; Sugano T; Okade H; Sato N; Shibata Y; Sakanashi D; Asai N; Koizumi Y; Suematsu H; Yamagishi Y; Mikamo H
    Int J Antimicrob Agents; 2021 May; 57(5):106330. PubMed ID: 33789129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of OXA-48-like and NDM carbapenemases producing Klebsiella pneumoniae in Jordan: A pilot study.
    Aqel AA; Giakkoupi P; Alzoubi H; Masalha I; Ellington MJ; Vatopoulos A
    J Infect Public Health; 2017; 10(2):150-155. PubMed ID: 26993738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of New Delhi Metallo-Beta-Lactamase (NDM) and
    Hoang CQ; Nguyen HD; Vu HQ; Nguyen AT; Pham BT; Tran TL; Nguyen HTH; Dao YM; Nguyen TSM; Nguyen DA; Tran HTT; Phan LT
    Biomed Res Int; 2019; 2019():9757625. PubMed ID: 31179337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increasing Prevalence of
    Devi LS; Broor S; Rautela RS; Grover SS; Chakravarti A; Chattopadhya D
    Int J Appl Basic Med Res; 2020; 10(3):156-163. PubMed ID: 33088736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016).
    Wang Q; Wang X; Wang J; Ouyang P; Jin C; Wang R; Zhang Y; Jin L; Chen H; Wang Z; Zhang F; Cao B; Xie L; Liao K; Gu B; Yang C; Liu Z; Ma X; Jin L; Zhang X; Man S; Li W; Pei F; Xu X; Jin Y; Ji P; Wang H
    Clin Infect Dis; 2018 Nov; 67(suppl_2):S196-S205. PubMed ID: 30423057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vitro activity of fosfomycin against
    Zarakolu P; Eser ÖK; Otlu B; Gürpınar Ö; Özakın C; Akalın H; Köksal İ; Ünal S
    J Chemother; 2022 Jul; 34(4):235-240. PubMed ID: 34495816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel Carbapenem-Resistant
    Gondal AJ; Saleem S; Jahan S; Choudhry N; Yasmin N
    Infect Drug Resist; 2020; 13():2105-2115. PubMed ID: 32669863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbapenem-Resistant
    Ramadan RA; Bedawy AM; Negm EM; Hassan TH; Ibrahim DA; ElSheikh SM; Amer RM
    Infect Drug Resist; 2022; 15():3537-3548. PubMed ID: 35833009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology and in vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates.
    Maraki S; Mavromanolaki VE; Magkafouraki E; Moraitis P; Stafylaki D; Kasimati A; Scoulica E
    Infection; 2022 Apr; 50(2):467-474. PubMed ID: 34854060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin.
    Giske CG; Gezelius L; Samuelsen Ø; Warner M; Sundsfjord A; Woodford N
    Clin Microbiol Infect; 2011 Apr; 17(4):552-6. PubMed ID: 20597925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spread of NDM-producing Klebsiella pneumoniae in a tertiary Greek hospital.
    Kontopoulou Κ; Meletis G; Pappa S; Zotou S; Tsioka K; Dimitriadou P; Antoniadou E; Papa A
    Acta Microbiol Immunol Hung; 2021 Mar; ():. PubMed ID: 33661135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant
    Han R; Shi Q; Wu S; Yin D; Peng M; Dong D; Zheng Y; Guo Y; Zhang R; Hu F;
    Front Cell Infect Microbiol; 2020; 10():314. PubMed ID: 32719751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.